Proactiveinvestors Australia Paradigm Biopharmaceuticals Ltd https://www.proactiveinvestors.com.au Proactiveinvestors Australia Paradigm Biopharmaceuticals Ltd RSS feed en Mon, 16 Dec 2019 03:41:16 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Paradigm Biopharmaceuticals provides market update https://www.proactiveinvestors.com.au/companies/news/909016/paradigm-biopharmaceuticals-provides-market-update-909016.html Wed, 11 Dec 2019 22:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/909016/paradigm-biopharmaceuticals-provides-market-update-909016.html Paradigm Biopharmaceuticals’ board member buys $300,000 worth of shares https://www.proactiveinvestors.com.au/companies/news/907407/paradigm-biopharmaceuticals-board-member-buys-300000-worth-of-shares-907407.html Tue, 19 Nov 2019 21:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/907407/paradigm-biopharmaceuticals-board-member-buys-300000-worth-of-shares-907407.html Paradigm Biopharmaceuticals’ Paul Rennie adds over $500,000 stock to holding https://www.proactiveinvestors.com.au/companies/news/907135/paradigm-biopharmaceuticals-paul-rennie-adds-over-500000-stock-to-holding-907135.html Thu, 14 Nov 2019 22:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/907135/paradigm-biopharmaceuticals-paul-rennie-adds-over-500000-stock-to-holding-907135.html Paradigm Biopharmaceuticals targets 2019-20 milestones for OA-MPS-BMEL pipeline https://www.proactiveinvestors.com.au/companies/news/906485/paradigm-biopharmaceuticals-targets-2019-20-milestones-for-oa-mps-bmel-pipeline-906485.html Thu, 07 Nov 2019 02:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/906485/paradigm-biopharmaceuticals-targets-2019-20-milestones-for-oa-mps-bmel-pipeline-906485.html Paradigm Biopharmaceuticals shares get a boost following IRB approval to treat ex NFL players https://www.proactiveinvestors.com.au/companies/news/905608/paradigm-biopharmaceuticals-shares-get-a-boost-following-irb-approval-to-treat-ex-nfl-players-905608.html Fri, 25 Oct 2019 06:10:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905608/paradigm-biopharmaceuticals-shares-get-a-boost-following-irb-approval-to-treat-ex-nfl-players-905608.html Paradigm Biopharmaceuticals journal publication confirms discovery, shares surge https://www.proactiveinvestors.com.au/companies/news/903696/paradigm-biopharmaceuticals-journal-publication-confirms-discovery-shares-surge-903696.html Mon, 30 Sep 2019 06:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/903696/paradigm-biopharmaceuticals-journal-publication-confirms-discovery-shares-surge-903696.html Paradigm Biopharmaceuticals gets FDA clearance for investigational new drug application https://www.proactiveinvestors.com.au/companies/news/902342/paradigm-biopharmaceuticals-gets-fda-clearance-for-investigational-new-drug-application-902342.html Tue, 10 Sep 2019 02:36:00 +1000 https://www.proactiveinvestors.com.au/companies/news/902342/paradigm-biopharmaceuticals-gets-fda-clearance-for-investigational-new-drug-application-902342.html Paradigm Biopharmaceuticals makes new breakthrough for iPPS, shares rise https://www.proactiveinvestors.com.au/companies/news/901671/paradigm-biopharmaceuticals-makes-new-breakthrough-for-ipps-shares-rise-901671.html Thu, 29 Aug 2019 01:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/901671/paradigm-biopharmaceuticals-makes-new-breakthrough-for-ipps-shares-rise-901671.html Paradigm Biopharmaceuticals files Investigational New Drug submission for ZilosulÒ with FDA https://www.proactiveinvestors.com.au/companies/news/900252/paradigm-biopharmaceuticals-files-investigational-new-drug-submission-for-zilosul-with-fda-900252.html Wed, 07 Aug 2019 01:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900252/paradigm-biopharmaceuticals-files-investigational-new-drug-submission-for-zilosul-with-fda-900252.html Paradigm Biopharmaceuticals director acquires 140,000 shares valued at almost $170,000 https://www.proactiveinvestors.com.au/companies/news/223250/paradigm-biopharmaceuticals-director-acquires-140000-shares-valued-at-almost-170000-223250.html Wed, 03 Jul 2019 06:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223250/paradigm-biopharmaceuticals-director-acquires-140000-shares-valued-at-almost-170000-223250.html Paradigm Biopharmaceuticals CEO shows faith in company with $49,000 on-market purchase https://www.proactiveinvestors.com.au/companies/news/223170/paradigm-biopharmaceuticals-ceo-shows-faith-in-company-with-49000-on-market-purchase-223170.html Tue, 02 Jul 2019 06:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223170/paradigm-biopharmaceuticals-ceo-shows-faith-in-company-with-49000-on-market-purchase-223170.html Paradigm Biopharmaceuticals Ltd fully funded as it advances iPPS development https://www.proactiveinvestors.com.au/companies/news/223006/paradigm-biopharmaceuticals-ltd-fully-funded-as-it-advances-ipps-development-223006.html Fri, 28 Jun 2019 05:59:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223006/paradigm-biopharmaceuticals-ltd-fully-funded-as-it-advances-ipps-development-223006.html Paradigm Biopharmaceuticals receives positive results for Ross River clinical trial https://www.proactiveinvestors.com.au/companies/news/221424/paradigm-biopharmaceuticals-receives-positive-results-for-ross-river-clinical-trial-221424.html Mon, 03 Jun 2019 23:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221424/paradigm-biopharmaceuticals-receives-positive-results-for-ross-river-clinical-trial-221424.html Paradigm Biopharmaceuticals receives more positive real-world patient data https://www.proactiveinvestors.com.au/companies/news/220992/paradigm-biopharmaceuticals-receives-more-positive-real-world-patient-data-220992.html Mon, 27 May 2019 23:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220992/paradigm-biopharmaceuticals-receives-more-positive-real-world-patient-data-220992.html Paradigm Biopharmaceuticals completes retail component of $26.3 million entitlement offer https://www.proactiveinvestors.com.au/companies/news/219926/paradigm-biopharmaceuticals-completes-retail-component-of-263-million-entitlement-offer-219926.html Thu, 09 May 2019 01:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219926/paradigm-biopharmaceuticals-completes-retail-component-of-263-million-entitlement-offer-219926.html Paradigm Biopharmaceuticals completes institutional component of $26.3 million entitlement offer https://www.proactiveinvestors.com.au/companies/news/218998/paradigm-biopharmaceuticals-completes-institutional-component-of-263-million-entitlement-offer-218998.html Wed, 24 Apr 2019 04:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218998/paradigm-biopharmaceuticals-completes-institutional-component-of-263-million-entitlement-offer-218998.html Paradigm Biopharmaceuticals director buys shares on-market https://www.proactiveinvestors.com.au/companies/news/218985/paradigm-biopharmaceuticals-director-buys-shares-on-market-218985.html Tue, 23 Apr 2019 22:33:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218985/paradigm-biopharmaceuticals-director-buys-shares-on-market-218985.html Paradigm Biopharmaceuticals secures $61.3 million in first stage of raising https://www.proactiveinvestors.com.au/companies/news/218723/paradigm-biopharmaceuticals-secures-613-million-in-first-stage-of-raising-218723.html Wed, 17 Apr 2019 00:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218723/paradigm-biopharmaceuticals-secures-613-million-in-first-stage-of-raising-218723.html Paradigm Biopharmaceuticals phase 2b trial achieves key endpoints in OA of the knee https://www.proactiveinvestors.com.au/companies/news/218542/paradigm-biopharmaceuticals-phase-2b-trial-achieves-key-endpoints-in-oa-of-the-knee-218542.html Mon, 15 Apr 2019 04:22:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218542/paradigm-biopharmaceuticals-phase-2b-trial-achieves-key-endpoints-in-oa-of-the-knee-218542.html Paradigm Biopharmaceuticals raising $77.9 million to fund its pivotal phase 3 OA trial https://www.proactiveinvestors.com.au/companies/news/218535/paradigm-biopharmaceuticals-raising-779-million-to-fund-its-pivotal-phase-3-oa-trial-218535.html Mon, 15 Apr 2019 02:27:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218535/paradigm-biopharmaceuticals-raising-779-million-to-fund-its-pivotal-phase-3-oa-trial-218535.html Paradigm Biopharmaceuticals gets a speeding ticket for 18% price increase https://www.proactiveinvestors.com.au/companies/news/217370/paradigm-biopharmaceuticals-gets-a-speeding-ticket-for-18-price-increase-217370.html Wed, 27 Mar 2019 23:42:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217370/paradigm-biopharmaceuticals-gets-a-speeding-ticket-for-18-price-increase-217370.html Paradigm Biopharmaceuticals director shows confidence with on-market share purchase https://www.proactiveinvestors.com.au/companies/news/216057/paradigm-biopharmaceuticals-director-shows-confidence-with-on-market-share-purchase-216057.html Fri, 08 Mar 2019 04:29:00 +1100 https://www.proactiveinvestors.com.au/companies/news/216057/paradigm-biopharmaceuticals-director-shows-confidence-with-on-market-share-purchase-216057.html Paradigm Biopharmaceuticals moving towards phase 2/3 MPS clinical trial https://www.proactiveinvestors.com.au/companies/news/214598/paradigm-biopharmaceuticals-moving-towards-phase-23-mps-clinical-trial-214598.html Thu, 14 Feb 2019 01:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/214598/paradigm-biopharmaceuticals-moving-towards-phase-23-mps-clinical-trial-214598.html Paradigm Biopharmaceuticals to court partners and licensees for OA drug commercialisation https://www.proactiveinvestors.com.au/companies/news/213114/paradigm-biopharmaceuticals-to-court-partners-and-licensees-for-oa-drug-commercialisation-213114.html Wed, 23 Jan 2019 04:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213114/paradigm-biopharmaceuticals-to-court-partners-and-licensees-for-oa-drug-commercialisation-213114.html Paradigm Biopharmaceutical shares surge on clinical trial success https://www.proactiveinvestors.com.au/companies/news/211356/paradigm-biopharmaceutical-shares-surge-on-clinical-trial-success-211356.html Tue, 18 Dec 2018 03:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211356/paradigm-biopharmaceutical-shares-surge-on-clinical-trial-success-211356.html Paradigm Biopharmaceuticals to talk clinical trial results on conference call tomorrow morning https://www.proactiveinvestors.com.au/companies/news/211284/paradigm-biopharmaceuticals-to-talk-clinical-trial-results-on-conference-call-tomorrow-morning-211284.html Mon, 17 Dec 2018 04:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211284/paradigm-biopharmaceuticals-to-talk-clinical-trial-results-on-conference-call-tomorrow-morning-211284.html Paradigm Biopharmaceuticals has results pending for phase 2b clinical trial https://www.proactiveinvestors.com.au/companies/news/211191/paradigm-biopharmaceuticals-has-results-pending-for-phase-2b-clinical-trial-211191.html Fri, 14 Dec 2018 00:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211191/paradigm-biopharmaceuticals-has-results-pending-for-phase-2b-clinical-trial-211191.html Paradigm Biopharmaceuticals chief executive Paul Rennie buys more shares https://www.proactiveinvestors.com.au/companies/news/211113/paradigm-biopharmaceuticals-chief-executive-paul-rennie-buys-more-shares-211113.html Thu, 13 Dec 2018 05:31:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211113/paradigm-biopharmaceuticals-chief-executive-paul-rennie-buys-more-shares-211113.html Paradigm Biopharmaceuticals gets more real world evidence of treatment success https://www.proactiveinvestors.com.au/companies/news/210726/paradigm-biopharmaceuticals-gets-more-real-world-evidence-of-treatment-success-210726.html Thu, 06 Dec 2018 23:56:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210726/paradigm-biopharmaceuticals-gets-more-real-world-evidence-of-treatment-success-210726.html Paradigm Biopharmaceuticals gains on market with upcoming clinical trial read-out, wider treatment potential https://www.proactiveinvestors.com.au/companies/news/210374/paradigm-biopharmaceuticals-gains-on-market-with-upcoming-clinical-trial-read-out-wider-treatment-potential-210374.html Mon, 03 Dec 2018 08:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210374/paradigm-biopharmaceuticals-gains-on-market-with-upcoming-clinical-trial-read-out-wider-treatment-potential-210374.html Paradigm Biopharmaceuticals ‘next Australian blockbuster biotech’, according to Fiftyone Capital https://www.proactiveinvestors.com.au/companies/news/210347/paradigm-biopharmaceuticals-next-australian-blockbuster-biotech-according-to-fiftyone-capital-210347.html Mon, 03 Dec 2018 02:02:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210347/paradigm-biopharmaceuticals-next-australian-blockbuster-biotech-according-to-fiftyone-capital-210347.html Paradigm Biopharmaceuticals’ positive trial results potentially transformational, says Morgans research https://www.proactiveinvestors.com.au/companies/news/210271/paradigm-biopharmaceuticals-positive-trial-results-potentially-transformational-says-morgans-research-210271.html Fri, 30 Nov 2018 05:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210271/paradigm-biopharmaceuticals-positive-trial-results-potentially-transformational-says-morgans-research-210271.html Paradigm Biopharmaceuticals signs agreement for use of iPPS in treatment of MPS https://www.proactiveinvestors.com.au/companies/news/209715/paradigm-biopharmaceuticals-signs-agreement-for-use-of-ipps-in-treatment-of-mps-209715.html Thu, 22 Nov 2018 00:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/209715/paradigm-biopharmaceuticals-signs-agreement-for-use-of-ipps-in-treatment-of-mps-209715.html Paradigm Biopharmaceuticals boosts financial position with $2.32 million R&D tax rebate https://www.proactiveinvestors.com.au/companies/news/209235/paradigm-biopharmaceuticals-boosts-financial-position-with-232-million-rd-tax-rebate-209235.html Thu, 15 Nov 2018 00:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/209235/paradigm-biopharmaceuticals-boosts-financial-position-with-232-million-rd-tax-rebate-209235.html Paradigm Biopharmaceuticals enters agreement to treat US-based sportspeople https://www.proactiveinvestors.com.au/companies/news/207807/paradigm-biopharmaceuticals-enters-agreement-to-treat-us-based-sportspeople-207807.html Thu, 25 Oct 2018 05:21:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207807/paradigm-biopharmaceuticals-enters-agreement-to-treat-us-based-sportspeople-207807.html Paradigm Biopharmaceuticals secures $9 million to accelerate phase III https://www.proactiveinvestors.com.au/companies/news/207792/paradigm-biopharmaceuticals-secures-9-million-to-accelerate-phase-iii-207792.html Wed, 24 Oct 2018 23:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207792/paradigm-biopharmaceuticals-secures-9-million-to-accelerate-phase-iii-207792.html Paradigm Biopharmaceuticals enters trading halt ahead of capital raising https://www.proactiveinvestors.com.au/companies/news/207615/paradigm-biopharmaceuticals-enters-trading-halt-ahead-of-capital-raising-207615.html Tue, 23 Oct 2018 00:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207615/paradigm-biopharmaceuticals-enters-trading-halt-ahead-of-capital-raising-207615.html Paradigm Biopharmaceuticals finalises Ross River virus trial recruitment https://www.proactiveinvestors.com.au/companies/news/203653/paradigm-biopharmaceuticals-finalises-ross-river-virus-trial-recruitment-203653.html Tue, 28 Aug 2018 03:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/203653/paradigm-biopharmaceuticals-finalises-ross-river-virus-trial-recruitment-203653.html Paradigm Biopharmaceuticals new data shows 60% pain reduction, shares rise https://www.proactiveinvestors.com.au/companies/news/202902/paradigm-biopharmaceuticals-new-data-shows-60-pain-reduction-shares-rise-202902.html Wed, 15 Aug 2018 00:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/202902/paradigm-biopharmaceuticals-new-data-shows-60-pain-reduction-shares-rise-202902.html Paradigm Biopharmaceuticals completes recruitment for knee pain trial https://www.proactiveinvestors.com.au/companies/news/202244/paradigm-biopharmaceuticals-completes-recruitment-for-knee-pain-trial-202244.html Mon, 06 Aug 2018 00:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/202244/paradigm-biopharmaceuticals-completes-recruitment-for-knee-pain-trial-202244.html Paradigm Biopharmaceuticals’ leaping share price attracts ASX speeding ticket https://www.proactiveinvestors.com.au/companies/news/200320/paradigm-biopharmaceuticals-leaping-share-price-attracts-asx-speeding-ticket-200320.html Mon, 09 Jul 2018 02:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/200320/paradigm-biopharmaceuticals-leaping-share-price-attracts-asx-speeding-ticket-200320.html Paradigm Biopharmaceuticals patients report over 50% pain reduction https://www.proactiveinvestors.com.au/companies/news/198908/paradigm-biopharmaceuticals-patients-report-over-50-pain-reduction-198908.html Fri, 15 Jun 2018 00:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198908/paradigm-biopharmaceuticals-patients-report-over-50-pain-reduction-198908.html Paradigm Biopharmaceuticals osteoarthritis clinical trial ahead of schedule https://www.proactiveinvestors.com.au/companies/news/197147/paradigm-biopharmaceuticals-osteoarthritis-clinical-trial-ahead-of-schedule-197147.html Thu, 17 May 2018 00:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/197147/paradigm-biopharmaceuticals-osteoarthritis-clinical-trial-ahead-of-schedule-197147.html Paradigm Biopharmaceuticals banking on near-term revenues from repurposing FDA approved drugs https://www.proactiveinvestors.com.au/companies/news/196873/paradigm-biopharmaceuticals-banking-on-near-term-revenues-from-repurposing-fda-approved-drugs-196873.html Mon, 14 May 2018 05:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196873/paradigm-biopharmaceuticals-banking-on-near-term-revenues-from-repurposing-fda-approved-drugs-196873.html Paradigm Biopharmaceuticals achieves pain treatment win with AFL players https://www.proactiveinvestors.com.au/companies/news/194287/paradigm-biopharmaceuticals-achieves-pain-treatment-win-with-afl-players-194287.html Thu, 05 Apr 2018 07:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/194287/paradigm-biopharmaceuticals-achieves-pain-treatment-win-with-afl-players-194287.html Paradigm Biopharmaceuticals’ osteoarthritis trial remains ahead of schedule https://www.proactiveinvestors.com.au/companies/news/193829/paradigm-biopharmaceuticals-osteoarthritis-trial-remains-ahead-of-schedule-193829.html Tue, 27 Mar 2018 00:21:00 +1100 https://www.proactiveinvestors.com.au/companies/news/193829/paradigm-biopharmaceuticals-osteoarthritis-trial-remains-ahead-of-schedule-193829.html Paradigm Biopharmaceuticals has success with PPS osteoarthritis treatment https://www.proactiveinvestors.com.au/companies/news/192384/paradigm-biopharmaceuticals-has-success-with-pps-osteoarthritis-treatment-192384.html Wed, 28 Feb 2018 22:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/192384/paradigm-biopharmaceuticals-has-success-with-pps-osteoarthritis-treatment-192384.html Paradigm Biopharmaceuticals adds AFL legend to list of osteoarthritis treatment wins https://www.proactiveinvestors.com.au/companies/news/190792/paradigm-biopharmaceuticals-adds-afl-legend-to-list-of-osteoarthritis-treatment-wins-190792.html Tue, 30 Jan 2018 01:19:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190792/paradigm-biopharmaceuticals-adds-afl-legend-to-list-of-osteoarthritis-treatment-wins-190792.html Paradigm Biopharmaceuticals eyes opportunities to treat osteoarthritis https://www.proactiveinvestors.com.au/companies/news/190512/paradigm-biopharmaceuticals-eyes-opportunities-to-treat-osteoarthritis-190512.html Wed, 24 Jan 2018 04:49:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190512/paradigm-biopharmaceuticals-eyes-opportunities-to-treat-osteoarthritis-190512.html Paradigm Biopharmaceuticals granted European patent https://www.proactiveinvestors.com.au/companies/news/190053/paradigm-biopharmaceuticals-granted-european-patent-190053.html Mon, 15 Jan 2018 23:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190053/paradigm-biopharmaceuticals-granted-european-patent-190053.html Paradigm Biopharmaceuticals ahead of schedule with trials https://www.proactiveinvestors.com.au/companies/news/187680/paradigm-biopharmaceuticals-ahead-of-schedule-with-trials-187680.html Wed, 22 Nov 2017 22:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/187680/paradigm-biopharmaceuticals-ahead-of-schedule-with-trials-187680.html Paradigm Biopharmaceuticals meets primary endpoint in clinical trial https://www.proactiveinvestors.com.au/companies/news/187194/paradigm-biopharmaceuticals-meets-primary-endpoint-in-clinical-trial-187194.html Tue, 14 Nov 2017 05:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/187194/paradigm-biopharmaceuticals-meets-primary-endpoint-in-clinical-trial-187194.html Paradigm Biopharmaceuticals funded into 2019 through placement https://www.proactiveinvestors.com.au/companies/news/186770/paradigm-biopharmaceuticals-funded-into-2019-through-placement-186770.html Mon, 06 Nov 2017 04:09:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186770/paradigm-biopharmaceuticals-funded-into-2019-through-placement-186770.html Paradigm Biopharmaceuticals to finalise raising https://www.proactiveinvestors.com.au/companies/news/186609/paradigm-biopharmaceuticals-to-finalise-raising-186609.html Wed, 01 Nov 2017 22:26:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186609/paradigm-biopharmaceuticals-to-finalise-raising-186609.html Paradigm has successfully dosed first participant in clinical trial for osteoarthritis https://www.proactiveinvestors.com.au/companies/news/186392/paradigm-has-successfully-dosed-first-participant-in-clinical-trial-for-osteoarthritis-186392.html Mon, 30 Oct 2017 04:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186392/paradigm-has-successfully-dosed-first-participant-in-clinical-trial-for-osteoarthritis-186392.html Paradigm reveals outcomes from patient case studies on Osteoarthritis https://www.proactiveinvestors.com.au/companies/news/185371/paradigm-reveals-outcomes-from-patient-case-studies-on-osteoarthritis-185371.html Wed, 11 Oct 2017 00:02:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185371/paradigm-reveals-outcomes-from-patient-case-studies-on-osteoarthritis-185371.html Paradigm Biopharmaceuticals receives ethics approval for trial on knee osteoarthritis https://www.proactiveinvestors.com.au/companies/news/184250/paradigm-biopharmaceuticals-receives-ethics-approval-for-trial-on-knee-osteoarthritis-184250.html Tue, 19 Sep 2017 23:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/184250/paradigm-biopharmaceuticals-receives-ethics-approval-for-trial-on-knee-osteoarthritis-184250.html Paradigm's Paul Rennie discusses momentum of the Ross River Virus Clinical Trial https://www.proactiveinvestors.com.au/companies/news/183949/paradigm-s-paul-rennie-discusses-momentum-of-the-ross-river-virus-clinical-trial-183949.html Thu, 14 Sep 2017 03:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183949/paradigm-s-paul-rennie-discusses-momentum-of-the-ross-river-virus-clinical-trial-183949.html Paradigm Biopharmaceuticals shares continue uptrend on leverage to Pentosan Polysulfate Sodium https://www.proactiveinvestors.com.au/companies/news/183786/paradigm-biopharmaceuticals-shares-continue-uptrend-on-leverage-to-pentosan-polysulfate-sodium-183786.html Mon, 11 Sep 2017 23:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183786/paradigm-biopharmaceuticals-shares-continue-uptrend-on-leverage-to-pentosan-polysulfate-sodium-183786.html Paradigm's drug developments sees growing market opportunities https://www.proactiveinvestors.com.au/companies/news/307931/paradigm-s-drug-developments-sees-growing-market-opportunities-7931.html Thu, 17 Aug 2017 22:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/307931/paradigm-s-drug-developments-sees-growing-market-opportunities-7931.html Paradigm Biopharmaceuticals doses first Ross River participant https://www.proactiveinvestors.com.au/companies/news/182159/paradigm-biopharmaceuticals-doses-first-ross-river-participant-182159.html Wed, 09 Aug 2017 01:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/182159/paradigm-biopharmaceuticals-doses-first-ross-river-participant-182159.html Paradigm Biopharmaceuticals Ltd to commence Ross River trial https://www.proactiveinvestors.com.au/companies/news/180558/paradigm-biopharmaceuticals-ltd-to-commence-ross-river-trial-180558.html Sun, 09 Jul 2017 23:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/180558/paradigm-biopharmaceuticals-ltd-to-commence-ross-river-trial-180558.html Paradigm Biopharmaceuticals CEO lifts stake over 22% https://www.proactiveinvestors.com.au/companies/news/179934/paradigm-biopharmaceuticals-ceo-lifts-stake-over-22-179934.html Wed, 28 Jun 2017 01:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179934/paradigm-biopharmaceuticals-ceo-lifts-stake-over-22-179934.html Paradigm Biopharmaceuticals CEO buys shares on-market https://www.proactiveinvestors.com.au/companies/news/179783/paradigm-biopharmaceuticals-ceo-buys-shares-on-market-179783.html Mon, 26 Jun 2017 04:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179783/paradigm-biopharmaceuticals-ceo-buys-shares-on-market-179783.html Paradigm Biopharmaceuticals enters US$18 billion global heart failure market https://www.proactiveinvestors.com.au/companies/news/179495/paradigm-biopharmaceuticals-enters-us18-billion-global-heart-failure-market-179495.html Tue, 20 Jun 2017 02:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179495/paradigm-biopharmaceuticals-enters-us18-billion-global-heart-failure-market-179495.html Paradigm Biopharmaceuticals receives hay fever update https://www.proactiveinvestors.com.au/companies/news/179349/paradigm-biopharmaceuticals-receives-hay-fever-update-179349.html Fri, 16 Jun 2017 01:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179349/paradigm-biopharmaceuticals-receives-hay-fever-update-179349.html Paradigm Biopharmaceuticals in a trading halt as news pending https://www.proactiveinvestors.com.au/companies/news/179268/paradigm-biopharmaceuticals-in-a-trading-halt-as-news-pending-179268.html Thu, 15 Jun 2017 01:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179268/paradigm-biopharmaceuticals-in-a-trading-halt-as-news-pending-179268.html Paradigm Biopharmaceuticals gets approval for Ross River trial https://www.proactiveinvestors.com.au/companies/news/178085/paradigm-biopharmaceuticals-gets-approval-for-ross-river-trial-178085.html Sun, 21 May 2017 23:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/178085/paradigm-biopharmaceuticals-gets-approval-for-ross-river-trial-178085.html Paradigm Biopharmaceuticals: Access latest PPT from Proactive's CEO Sessions https://www.proactiveinvestors.com.au/companies/news/177944/paradigm-biopharmaceuticals-access-latest-ppt-from-proactive-s-ceo-sessions-177944.html Thu, 18 May 2017 22:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177944/paradigm-biopharmaceuticals-access-latest-ppt-from-proactive-s-ceo-sessions-177944.html Paradigm Biopharmaceuticals has hay fever study published https://www.proactiveinvestors.com.au/companies/news/177823/paradigm-biopharmaceuticals-has-hay-fever-study-published-177823.html Tue, 16 May 2017 01:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177823/paradigm-biopharmaceuticals-has-hay-fever-study-published-177823.html Paradigm Biopharmaceuticals receives valuable grant https://www.proactiveinvestors.com.au/companies/news/177620/paradigm-biopharmaceuticals-receives-valuable-grant-177620.html Thu, 11 May 2017 01:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177620/paradigm-biopharmaceuticals-receives-valuable-grant-177620.html Paradigm Biopharmaceuticals brings Phase 2 milestone news flow to Spotlight CEO Sessions https://www.proactiveinvestors.com.au/companies/news/177395/paradigm-biopharmaceuticals-brings-phase-2-milestone-news-flow-to-spotlight-ceo-sessions-177395.html Mon, 08 May 2017 22:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177395/paradigm-biopharmaceuticals-brings-phase-2-milestone-news-flow-to-spotlight-ceo-sessions-177395.html Paradigm Biopharmaceuticals treats final patient in hay fever trial https://www.proactiveinvestors.com.au/companies/news/175258/paradigm-biopharmaceuticals-treats-final-patient-in-hay-fever-trial-175258.html Thu, 23 Mar 2017 01:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/175258/paradigm-biopharmaceuticals-treats-final-patient-in-hay-fever-trial-175258.html Paradigm Biopharmaceuticals gets cash boost from rebate https://www.proactiveinvestors.com.au/companies/news/175173/paradigm-biopharmaceuticals-gets-cash-boost-from-rebate-175173.html Wed, 22 Mar 2017 00:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/175173/paradigm-biopharmaceuticals-gets-cash-boost-from-rebate-175173.html Paradigm Biopharmaceuticals to test Ross River treatment https://www.proactiveinvestors.com.au/companies/news/174356/paradigm-biopharmaceuticals-to-test-ross-river-treatment-174356.html Tue, 07 Mar 2017 03:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/174356/paradigm-biopharmaceuticals-to-test-ross-river-treatment-174356.html Paradigm Biopharmaceuticals shines under broker spotlight https://www.proactiveinvestors.com.au/companies/news/174165/paradigm-biopharmaceuticals-shines-under-broker-spotlight-174165.html Thu, 02 Mar 2017 22:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/174165/paradigm-biopharmaceuticals-shines-under-broker-spotlight-174165.html Paradigm Biopharmaceuticals completes recruitment for hay fever trial https://www.proactiveinvestors.com.au/companies/news/172137/paradigm-biopharmaceuticals-completes-recruitment-for-hay-fever-trial-172137.html Tue, 24 Jan 2017 20:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/172137/paradigm-biopharmaceuticals-completes-recruitment-for-hay-fever-trial-172137.html Paradigm Biopharmaceuticals Ltd to begin allergic rhinitis trial in Sweden https://www.proactiveinvestors.com.au/companies/news/169306/paradigm-biopharmaceuticals-ltd-to-begin-allergic-rhinitis-trial-in-sweden-169306.html Tue, 22 Nov 2016 02:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/169306/paradigm-biopharmaceuticals-ltd-to-begin-allergic-rhinitis-trial-in-sweden-169306.html Paradigm Biopharmaceuticals heads to market https://www.proactiveinvestors.com.au/companies/news/167396/paradigm-biopharmaceuticals-heads-to-market-167396.html Thu, 13 Oct 2016 23:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/167396/paradigm-biopharmaceuticals-heads-to-market-167396.html Paradigm Biopharmaceuticals Ltd clears initial safety review of nasal spray https://www.proactiveinvestors.com.au/companies/news/165535/paradigm-biopharmaceuticals-ltd-clears-initial-safety-review-of-nasal-spray-70565.html Fri, 19 Aug 2016 03:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/165535/paradigm-biopharmaceuticals-ltd-clears-initial-safety-review-of-nasal-spray-70565.html